Combined thrombolytic therapy for prosthetic mitral valve thrombosis

Keyphrases

• Combination Therapy 33%
• Emergent Treatment 33%
• High Mortality 33%
• Infusion Time 33%
• Long Half-life 33%
• Postpartum Patient 33%
• Prolonged Infusion 33%
• Prosthetic Mitral Valve 100%
• Prosthetic Valve Thrombosis 33%
• Thrombolytic Therapy 100%
• Thrombosis 33%
• Tissue Plasminogen Activator (t-PA) 33%
• Treatment Choice 33%
• Treatment Options 33%
• Unacceptable Risk 33%
• Urokinase 33%
• Valve Thrombosis 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Combination Therapy 33%
• Fibrinolytic Agent 100%
• Prosthetic Valve Thrombosis 100%
• Tissue Plasminogen Activator 33%
• Urokinase 33%